A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity. (Q38348323)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14605668%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14605668%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14605668%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Carla A London

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14605668%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Harmanjatinder S Sekhon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14605668%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Vikram Arora

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14605668%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

David A Stein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14605668%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Gayathri R Devi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14605668%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14605668%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14605668%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14605668%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14605668%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

823-832

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14605668%20AND%20SRC:MED&resulttype=core&format=json

Anti-androgens and other hormonal therapies for prostate cancer

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Prostate cancer: molecular biology of early progression to androgen independence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

How matrix metalloproteinases regulate cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Strategies for MMP inhibition in cancer: innovations for the post-trial era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Morpholino antisense oligomers: design, preparation, and properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Antiproliferative effects of steric blocking phosphorodiamidate morpholino antisense agents directed against c-myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Antisense oligonucleotides to gastrin inhibit growth of human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Angiogenesis-dependent diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

MMP inhibition in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Effect of IGFBP-3 on IGF- and IGF-analogue-induced insulin-like growth factor-I receptor (IGFIR) signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Morpholino antisense oligomers: the case for an RNase H-independent structural type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Bioavailability and efficacy of antisense morpholino oligomers targeted to c-myc and cytochrome P-450 3A2 following oral administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Transdermal use of phosphorodiamidate morpholino oligomer AVI-4472 inhibits cytochrome P450 3A2 activity in male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Inhibition of coagulation by a phosphorothioate oligonucleotide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Bolus intravenous injection of phosphorothioate oligonucleotides causes hypotension by acting as alpha(1)-adrenergic receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

Expression of matrix metalloproteinase in the fluids of renal cystic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

7 January 2021

Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

7 January 2021

Expression of metalloproteinase genes in human prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

7 January 2021

Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

7 January 2021

Inverse relation between prostate-specific antigen and insulin-like growth factor-binding protein 3 in bone metastases and serum of patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

7 January 2021

Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

7 January 2021

Tumor angiogenesis and endothelial cell modulatory factors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

7 January 2021

Antisense morpholino oligonucleotide analog induces missplicing of C-myc mRNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

7 January 2021

Evaluation of antisense mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700642

7 January 2021